Table III.

Univariate and multivariate analyses with Cox proportional hazards regression model for biochemical recurrence-free survival.

Variables	HR (95% CI)	P-value
Univariate
miR-30c/BCL9 status	5.79 (1.28–26.19)	0.023
Gleason score	3.39 (2.10–5.47)	<0.001
Preoperative PSA	1.01 (1.01–1.04)	0.001
Pathological tumor stage	4.78 (1.84–12.37)	0.001
Surgical margin status	4.14 (1.63–10.53)	0.003
Multivariate
miR-30c/BCL9 status	5.08 (1.02–25.39)	0.048
Gleason score	6.89 (1.75–27.13)	0.006
Preoperative PSA	0.97 (0.89–1.05)	0.449
Pathological tumor stage	1.29 (0.20–5.79)	0.744
Surgical margin status	2.10 (0.60–7.31)	0.246

HR, hazard ratio; CI, confidence interval; miR, microRNA; BCL9, B-cell lymphoma 9; PSA, prostate-specific antigen.